Drug Stocks in Spotlight (Centene Corp, Amedisys Inc, Vical Incorporated, Volcano Corporation)

Houston, TX -- (SBWIRE) -- 02/15/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Centene Corp(NYSE:CNC) added 1.85% and is trading at $46.35. Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals. The Company provides member-focused services through locally based staff by assisting in accessing care, coordinating referrals to related health and social services and addressing member concerns and questions.

Can CNC Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Amedisys Inc(NASDAQ:AMED) is higher 1.00% and is trading at $13.03. Amedisys, Inc. (Amedisys) is a health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and their families, with approximately 11 million visits per year. The Company operates in two segments: home health and hospice.

How Should Investors Trade AMED After The Recent Volatile Moves? Find Out Here

Vical Incorporated(NASDAQ:VICL) added 0.60% and is trading at $3.36. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Is VICL Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Volcano Corporation(NASDAQ:VOLC) fell 1.24% and is trading at $25.58. Volcano Corporation (Volcano) designs, develops, manufactures and commercializes a range of precision guided therapy tools, including intravascular ultrasound (IVUS), and fractional flow reserve (FFR), products. The Company is facilitating the adoption of functional percutaneous interventional (PCI), in which its FFR technology is used to determine whether or not a stent is necessary, and IVUS is used to guide stent placement and optimization.

Can VOLC Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com